National Drug Abuse Treatment 

 NEW YORK NODE


NEW YORK NODE

John Rotrosen, M.D. [email]
Principal Investigator

Department of Psychiatry
New York University School of Medicine
423 East 23rd St., 17W
New York, NY 10010
http://www.med.nyu.edu/mhadrp/programs/national_drug_abuse.html (Node)
http://www.nida.nih.gov/CTN/centers/newyork.html (NIDA)

The New York Node joined the Clinical Trials Network in January 2000. This Node is a consortium of academic centers, clinical programs and local and regional agencies with a long track record of fruitful collaboration in research, training, service delivery, policy-making, funding, and advocacy for addictive disorders. Key academic institutions include the New York University School of Medicine (the Regional Research and Training Center (RRTC)), The Rockefeller University, the Nathan Kline Institute, and the NY Academy of Medicine. The node's eight CTPs provide a wide range of programs and treatment models, and services for more than 13,000 patients with extensive diagnostic, ethnic, and gender diversity. NY Node CTPs have been at the forefront of translational research and have made a number of pioneering achievements including the establishment of the first outpatient narcotic detoxification clinic, the first non-hospital-based methadone program, the first methadone-to-abstinence residential community, and the first social work field training in addiction.

  Find publications in the Library with New York Node involvement


  NEW YORK NODE PROTOCOL INVOLVEMENT

CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules

CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs

CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

CTN-0015 Women's Treatment for Trauma and Substance Use Disorders

CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Settings

CTN-0029 Attention Deficit Hyperactivity Disorder (ADHD) in Adult Smokers

CTN-0030

Prescription Opioid Addiction Treatment Study (POATS)


CTN-0030-A-1 Collection of Economic Data for the Prescription Opioid Addiction Treatment Study

 


 

 

 

  

 

 

 




Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2010 -- http://ctndisseminationlibrary.org/nodes/nynode.htm
info@ctndisseminationlibrary.org